Oncology

Latest News

OTC Colon Cancer Screening Test Now Available in Pharmacies Across US
OTC Colon Cancer Screening Test Now Available in Pharmacies Across US

February 27th 2024

Reese Pharmaceutical’s ColoTest has a suggested retail price of $19.99 and will also be sold on major retail shelves later this spring.

Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple Myeloma
Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple Myeloma

February 21st 2024

FDA Grants Accelerated Approval to Lifileucel, First-Ever Immunotherapy For Unresectable, Metastatic Melanoma
FDA Grants Accelerated Approval to Lifileucel, First-Ever Immunotherapy For Unresectable, Metastatic Melanoma

February 19th 2024

 Incidence of Breast Cancer in US Highest Among Young Black Women
Incidence of Breast Cancer in US Highest Among Young Black Women

February 14th 2024

FDA Requests Black Box Warning for Approved CAR-T Therapies Over Secondary Cancer Concern
FDA Requests Black Box Warning for Approved CAR-T Therapies Over Secondary Cancer Concern

January 24th 2024

Latest CME Events & Activities

Optimizing Administration of CAR T-Cell Therapy in Multiple Myeloma Through Pharmacist Interventions

1.0 Credit / Oncology

View More

Managed Care Insights on Optimizing the Use of BCMA-Targeted Treatments in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Understanding the Role of BCMA-Directed Therapy in the Management of Relapsed/Refractory Multiple Myeloma

1.25 Credits / Hematology, Oncology

View More

Clinical Updates in the Treatment of HER2-Positive Breast Cancer

0.75 Credit / Oncology, Women's Health

View More

The Evolving Treatment Landscape for HR+/HER2- Breast Cancer: Updates and Considerations for Managed Care

1.5 Credits / Oncology, Women's Health

View More

Exploring Clinical Updates in HR+/HER2- Breast Cancer Treatment and the Impact on Patient Care

1.0 Credit / Oncology, Women’s Health

View More

BCMA-Targeted Treatments in Multiple Myeloma: Novel Approaches and Recent Advances

2.0 Credits / Oncology

View More

Clinical Conversations in Cancer Care: Preparing Pharmacists to Optimize Use of Bispecific Antibodies

1.5 Credits / Hematology, Oncology

View More

Innovations in Cancer Care: Examining the Emerging Role of Bispecific Antibodies in Relapsed/Refractory Lymphoma and Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

An In-depth Look at PARP Inhibitors and Their Role in the Treatment of Ovarian Cancer

1.5 Credits / Oncology, Women's Health

View More

Antibody-Drug Conjugates (ADCs): The Implications of Emerging Trends on Oncology Pharmacy Practice

0.75 Credit / Oncology

View More

Advancing Treatment Options for Endometrial Cancer: Updates for Pharmacists

0.75 Credit / Oncology, Women's Health

View More

Managed Care Approaches in Optimizing the Impact of PARP Inhibitors on Resource Utilization and Clinical Outcomes in Ovarian Cancer

1.5 Credits / Oncology, Women's Health

View More

Promoting Evidence-Based Care and Health Equity in Endometrial Cancer Through Managed Care Interventions

1.0 Credit / Oncology; Women’s Health

View More

Evaluating Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancer

2.0 Credits / Oncology

View More

Preventing and Managing Controlled Substance Diversion Across Health Care Settings

2.0 Credits / Law

View More

Drug Resistance and Toxicity Mitigation Strategies: Optimizing the Role of the Pharmacist in Management of Patients With Chronic Myeloid Leukemia

2.0 Credits / Oncology

View More

Risks and Liabilities in Pharmacy Practice

1.0 Credit / Law

View More

Exploring the New Standard of Care for the Frontline Treatment of Non-Small Cell Lung Cancer: A Focus on Immunotherapy

1.5 Credits / Oncology, Pulmonology/Respiratory

View More

Optimizing the Use of Targeted Therapies for the Treatment of ROS1-Rearranged and KRAS-Mutant Non−Small Cell Lung Cancer

1.0 Credits / Oncology

View More

2022 ASH Annual Meeting Coverage—Recent Developments in Diffuse Large B-Cell Lymphoma: Insights and Application for Managed Care

1.0 Credit / Oncology

View More

An Article in the American Journal of Managed Care’s Evidence-Based Oncology: Navigating the Complexities of Frontline Immunotherapy in NSCLC

2 Credits / Oncology, Pulmonology/Respiratory

View More

CAR T-Cell Therapy Advances in Lymphoma: Implications for Managed Care

1.5 Credits / Hematology, Oncology

View More

Evidence-Based Oncology: Discerning Novel Approaches, Recent Advances, and the Managed Care Considerations for Targeted Treatments in CLL

2.0 Credits / Hematology, Oncology

View More

Ensuring the Safe, Effective, and Equitable Care of Patients With Advanced Endometrial Cancer: Strategies for Oncology Pharmacists

April 4, 2024 | 1:35 PM ET

View More

Navigating Myelofibrosis: Tailored Treatments and Holistic Patient Support

April 5, 2024 | 11:00 AM ET

View More

Leveraging Managed Care to Increase Access to BCMA-Directed Treatment and Equitable Care in Multiple Myeloma

1.5 Credits / Hematology, Oncology

View More

Evidence and Managed Care Considerations for the Use of Novel Immunotherapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

1.5 Credits / Oncology

View More

Leveraging Managed Care to Optimize Patient Outcomes in Acute Myeloid Leukemia

1.5 Credits / Hematology, Oncology

View More

New Pathways in Care for Myelofibrosis: Optimizing Treatment to Improve Outcomes

1.5 Credits / Hematology, Oncology

View More

More News

© 2024 MJH Life Sciences

All rights reserved.